Company / Book Value per Share
Axsome Therapeutics, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$1.814
FY2025
5-year range
$0.416 / $4.39
FY2021-FY2025
Trend
+50.7%
vs FY2024
Sector context
#151 of 209
Health Care
What the data says
At $1.814, Axsome Therapeutics, Inc.'s book value per share ranks #151 of 209 in the Health Care sector. Book Value per Share has fluctuated over the past 10 years, ranging from $0.035 in FY2018 to $5.253 in FY2019.
Based on SEC 10-K filings.
$1.814 in FY2025 with a 5-year CAGR of -9.9%.
Declined from $4.39 to $1.814 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -14.4%
- 5-Year CAGR
- -9.9%
- 10-Year CAGR
- -
Sector benchmark
#151 of 209 in Health CareTop 72% of 209This company $1.814 Sector average $189.406
▼
-99.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -9.9%, indicating a declining trend.
- In FY2025, book value per share increased 50.7% year-over-year.
- Ranks #151 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.814 | +50.7% |
| FY2024 | $1.204 | -72.6% |
| FY2023 | $4.39 | +51.5% |
| FY2022 | $2.897 | +597.2% |
| FY2021 | $0.416 | -86.4% |
| FY2020 | $3.058 | -41.8% |
| FY2019 | $5.253 | +14957.9% |
| FY2018 | $0.035 | -95.2% |
| FY2017 | $0.734 | -34.8% |
| FY2016 | $1.126 | -71.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026